Missing Links?: 1093   Citation Matrix Graphs Glossary  HistCite Guide  About
Wed Oct 5 14:33:16 2005
Publications by W Szybalski
and the papers citing W Szybalski

Nodes: 10146, Authors: 16970, Journals: 1137, Outer References: 208320, Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name. Page 7 of 102: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31   41   51   61   71   81   91  |  101 

#LCRNCRNode / Date / Journal / AuthorLCSGCS
60114127752 1964 ANNUAL REVIEW OF NUCLEAR SCIENCE 14: 347-&
WHITMORE GF; TILL JE
QUANTITATION OF CELLULAR RADIOBIOLOGICAL RESPONSES
13160
602162791341 1967 ANNUAL REVIEW OF NUCLEAR SCIENCE 17: 469-&
GINOZA W
EFFECTS OF IONIZING RADIATION ON NUCLEIC ACIDS OF BACTERIOPHAGES AND BACTERIAL CELLS
115
60352181793 1969 ANNUAL REVIEW OF NUCLEAR SCIENCE 19: 139-&
BRIDGES BA
MECHANISMS OF RADIATION MUTAGENESIS IN CELLULAR AND SUBCELLULAR SYSTEMS
553
60412199937 1965 ANNUAL REVIEW OF PHARMACOLOGY 5: 53-&
BURCHALL JJ; FERONE R; HITCHING.GH
ANTIBACTERIAL CHEMOTHERAPY
25
605111781129 1966 ANNUAL REVIEW OF PHARMACOLOGY 6: 231-&
EGGERS HJ; TAMM I
ANTIVIRAL CHEMOTHERAPY
425
606192441342 1967 ANNUAL REVIEW OF PHARMACOLOGY 7: 101-&
HEIDELBERGER C
CANCER CHEMOTHERAPY WITH PURINE AND PYRIMIDINE ANALOGUES
459
607161061794 1969 ANNUAL REVIEW OF PHARMACOLOGY 9: 393-&
SCHINDLE.R
USE OF CELL CULTURE IN PHARMACOLOGY
012
608122402069 1970 ANNUAL REVIEW OF PHARMACOLOGY 10: 143-&
GOZ B; PRUSOFF WH
PHARMACOLOGY OF VIRUSES
1044
609151922414 1971 ANNUAL REVIEW OF PHARMACOLOGY 11: 369-&
YOUNG CW; BURCHENA.JH
CANCER CHEMOTHERAPY
011
610191782733 1972 ANNUAL REVIEW OF PHARMACOLOGY 12: 35-&
HASH JH
ANTIBIOTIC MECHANISMS
021
#LCRNCRNode / Date / Journal / AuthorLCSGCS
61127769596 1963 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 3: 357-&
KARNOFSKY DA; CLARKSON BD
CELLULAR EFFECTS OF ANTICANCER DRUGS
1181
61271933488 1974 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 14: 157-183
CARTER SK; SLAVIK M
CHEMOTHERAPY OF CANCER
129
61341308256 1990 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 30: 149-168
MASON JM; LANGENBACH R; SHELBY MD; ZEIGER E; TENNANT RW
ABILITY OF SHORT-TERM TESTS TO PREDICT CARCINOGENESIS IN RODENTS
013
614132042415 1971 ANNUAL REVIEW OF PHYSICAL CHEMISTRY 22: 25-&
CANTOR CR; KATZ L
NUCLEIC ACIDS
03
615120479 1954 ANNUAL REVIEW OF PHYSIOLOGY 16: 81-102
HOROWITZ NH; OWEN RD
PHYSIOLOGICAL ASPECTS OF GENETICS
112
6163196938 1965 ANNUAL REVIEW OF PHYTOPATHOLOGY 3: 231-&
STOLP H; STARR MP; BAIGENT NL
PROBLEMS IN SPECIATION OF PHYTOPATHOGENIC PSEUDOMONADS AND XANTHOMONADS
235
61741091343 1967 ANNUAL REVIEW OF PHYTOPATHOLOGY 5: 109-&
GEORGOPO.SG; ZARACOVI.C
TOLERANCE OF FUNGI TO ORGANIC FUNGICIDES
046
6183671527 1968 ANNUAL REVIEW OF PHYTOPATHOLOGY 6: 63-&
DELEY J
DNA BASE COMPOSITION AND HYBRIDIZATION IN TAXONOMY OF PHYTOPATHOGENIC BACTERIA
038
61961017187 1985 ANNUAL REVIEW OF PHYTOPATHOLOGY 23: 297-320
MILLS D
TRANSPOSON MUTAGENESIS AND ITS POTENTIAL FOR STUDYING VIRULENCE GENES IN PLANT-PATHOGENS
022
62051931795 1969 ANNUAL REVIEW OF PLANT PHYSIOLOGY 20: 63-&
GLASZIOU KT
CONTROL OF ENZYME FORMATION AND INACTIVATION IN PLANTS
289
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6213110341 1961 ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY 12: 327-&
TAYLOR JH
GROWTH AND DEVELOPMENT - PHYSIOLOGY OF MITOSIS AND MEIOSIS
18
6224217857 1988 ANTI-CANCER DRUG DESIGN 3 (1): 67-76
FERGUSON LR; PALMER BD; DENNY WA
MICROBIAL MUTAGENICITY OF CHLORAMBUCIL, ITS HALF-MUSTARD AND MITOMYCIN-C - A MODIFIED SCREENING STRATEGY FOR GENETIC TOXICOLOGY OF BIS-ALKYLATING ANTI-TUMOR DRUGS
116
6233308064 1989 ANTI-CANCER DRUG DESIGN 3 (4): 271-282
ELLIOTT JA; WILSON WD; SHEA RG; HARTLEY JA; RESZKA K; et al.
INTERACTION OF BISANTRENE ANTI-CANCER AGENTS WITH DNA - FOOTPRINTING, STRUCTURAL REQUIREMENTS FOR DNA UNWINDING, KINETICS AND MECHANISM OF BINDING AND CORRELATION OF STRUCTURAL AND KINETIC-PARAMETERS WITH ANTI-CANCER ACTIVITY
05
6246608458 1991 ANTI-CANCER DRUG DESIGN 6 (6): 569-584
HELENE C
THE ANTI-GENE STRATEGY - CONTROL OF GENE-EXPRESSION BY TRIPLEX-FORMING-OLIGONUCLEOTIDES
4259
6253319316 1996 ANTI-CANCER DRUG DESIGN 11 (8): 581-596
Gupta R; Liu JX; Xie GJ; Lown JW
Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: Synthesis, DNA sequence specificity and biological evaluation
06
62617849561 1998 ANTI-CANCER DRUG DESIGN 13 (6): 593-609
Jaffar M; Naylor MA; Robertson N; Stratford IJ
Targeting hypoxia with a new generation of indolequinones
024
6272358637 1992 ANTI-CANCER DRUGS 3 (1): 33-38
KUSUMOTO H; MAEHARA Y; YOSHIDA M; TAKAHASHI I; ANAI H; et al.
RELATIONSHIP BETWEEN TUMOR HISTOPATHOLOGY AND INVITRO SENSITIVITY TO ANTITUMOR DRUGS IN GASTRIC-CANCER
08
628001344 1967 ANTIBIOTICS 1: 211-245
SZYBALSKI W; IYER VN
The Mitomycins and Porfiromycins. (In: D. Gottlieb and P. D. Shaw (Eds.), Antibiotics, Vol. 1, Mechanism of Action)
174174
62911645 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (6): 581-586
FUSILLO MH; NOYES HE; PULASKI EJ; TOM JYS
ANTIMICROBIAL SPECTRUM AND CROSS RESISTANCE STUDIES OF ERYTHROMYCIN AND CARBOMYCIN
623
63011346 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (9): 915-919
SZYBALSKI W
NATURAL AND ARTIFICIAL PENICILLIN RESISTANCE IN STAPHYLOCOCCUS (MICROCOCCUS-PYOGENES VAR AUREUS)
3838
#LCRNCRNode / Date / Journal / AuthorLCSGCS
63132547 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (11): 1095-1103
SZYBALSKI W
GENETIC STUDIES ON MICROBIAL CROSS RESISTANCE TO TOXIC AGENTS .2. CROSS RESISTANCE OF MICROCOCCUS-PYOGENES VAR AUREUS TO 34 ANTIMICROBIAL DRUGS
2020
6321448 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (12): 1243-1246
VANDIJCK PJ; VANDEVOORDE HP; DESOMER P
PRELIMINARY NOTES ON GRISEOMYCIN, A NEW ANTIBIOTIC
09
6331980 1954 ANTIBIOTICS AND CHEMOTHERAPY 4 (3): 300-303
DENUNZIO JC; BOWMAN FW; KIRSHBAUM A
THE BIOLOGIC ASSAY OF NEOMYCIN IN COMBINATION WITH DIHYDROSTREPTOMYCIN, USING A TEST ORGANISM MADE RESISTANT TO DIHYDROSTREPTOMYCIN
02
634112342 1961 ANTIBIOTICS AND CHEMOTHERAPY 11 (3): 196-&
DOBRZANS.W
CONVERSION TO STREPTOMYCIN RESISTANCE (AKIBAS PHENOMENON) IN A PRESUMABLY STATIONARY POPULATION OF STAPHYLOCOCCUS AUREUS
00
63528343 1961 ANTIBIOTICS AND CHEMOTHERAPY 11 (12): 797-&
RAGNI G; BOROWSKI E; SCHAFFNER CP; SZYBALSKI W
N-ACETYLCANDIDIN, A WATER-SOLUBLE POLYENE ANTIBIOTIC FOR FUNGAL PROPHYLAXIS AND DECONTAMINATION OF TISSUE CULTURES
66
6363272344 1961 ANTIBIOTIKI 6 (5): 453-&
SAZYKIN YO
MECHANISM OF ACTIVITY OF ANTIBIOTICS ON METABOLISM OF MICROORGANISMS
02
637118345 1961 ANTIBIOTIKI 6 (7): 643-&
GAUZE GF; KOCHETKOV GV
VULNERABILITY OF NUCLEIC ACIDS IN MUTANT STAPHYLOCOCCI USED IN SCREENING FOR ANTICANCER PRODUCTS
00
6382122416 1971 ANTIBIOTIKI 16 (3): 218-&
KOLOBOV AV; ABIDOVA M; GUBERNIE.MA
EFFECT OF MITOMYCIN-C ON POLYNUCLEOTIDEPHOSPHORYLASE ACTIVITY IN EXPERIMENTS WITH MICROORGANISMS AND INTACT CELLS
00
639272417 1971 ANTIBIOTIKI 16 (5): 400-&
ESELEVIC.MM; SAZYKIN YO; TORBOCHK.LI
STUDIES ON MECHANISM OF ACTION OF VARIAMYCIN
02
6403132418 1971 ANTIBIOTIKI 16 (6): 487-&
DUDNIK YV; NETYKSA EM; VARIK OY
INCREASED ANTIBACTERIAL EFFECT OF BRUNEOMYCIN AND SIBIROMYCIN IN CULTURES WITH IMPAIRED REPERATION OF DNA
13
#LCRNCRNode / Date / Journal / AuthorLCSGCS
64131032734 1972 ANTIBIOTIKI 17 (2): 172-&
KOCHETKO.GV
MICROORGANISMS AS TEST-OBJECTS IN SCREENING PROGRAMS OF ANTITUMOR ANTIBIOTICS
00
6424103112 1973 ANTIBIOTIKI 18 (3): 223-227
TOLKACHE.EN; TIMOFEEV.EA
SENSITIVITY OF HUMAN TUMOR-CELLS IN CULTURE TO MITHOMYCIN C AND THIOPHOSPHAMIDE
01
6431163113 1973 ANTIBIOTIKI 18 (6): 566-568
KULYASH YV; SHENDERO.BA; FILIMONO.LS
STUDY OF TEMPERATURE EFFECT ON RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO SOME DRUGS AND ON ACTIVITY OF ENZYMES OF TERMINAL STAGE OF ELECTRON-TRANSPORT CHAIN
00
6443253114 1973 ANTIBIOTIKI 18 (9): 802-807
MAKAROVS.VV; PIRTSKHA.DS; SPITKOVS.DM; FEDOROV SN
CONDENSING EFFECT OF ACTINOMYCIN ON INTERACTION WITH NUCLEAR CHROMATIN OF SOMATIC-CELLS
02
6452153115 1973 ANTIBIOTIKI 18 (11): 968-973
DUDNIK YV; GAUZE GG; KARPOV VL; KOZMYAN LI; PADRON E
INTERACTION IN-VITRO OF BRUNEOMYCIN (STREPTONIGRIN) WITH DNA
18
6461233489 1974 ANTIBIOTIKI 19 (1): 74-78
MIRZAEVA MA
DEVELOPMENT OF RESISTANCE TO SOME ANTIBIOTICS IN BRUCELLA ON THEIR PASSAGES TO MEDIA WITH ANTIBIOTICS
00
6471103490 1974 ANTIBIOTIKI 19 (8): 729-732
ZHELEVA M; GENOVA YG; URUMOV A
SOME CHANGES IN ANTIGENIC COMPLEX OF BACILLUS ANTHRACIS UNDER STREPTOMYCIN EFFECT
00
6481143867 1975 ANTIBIOTIKI 20 (6): 488-494
LETYAGIN KP; BARTOSHEVICH YE; TETERYATNIK AF
VARIATION OF ACT-CIRCULATUS VAR MONOMYCINI INDUCED BY N-5-NITROZO-N-METHYLBIURET
00
6491125237 1979 ANTIBIOTIKI 24 (7): 498-502
NEMCHENKO VV; DOMBROVSKY AM
CHANGES IN BIOLOGICAL PROPERTIES OF SALMONELLA DURING DEVELOPMENT OF RESISTANCE TO CHLORAMPHENICOL
00
650195913 1981 ANTIBIOTIKI 26 (5): 345-349
TEREKHOVA LP; GALATENKO OA; PREOBRAZHENSKAYA TA
ANTIBIOTIC-SENSITIVITY OF ACTINOMYCETES BELONGING TO ACTINOMADURA
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6518706257 1982 ANTIBIOTIKI 27 (3): 221-234
KRYLOV AS
MOLECULAR-MODELS OF COMPLEXES OF DNA AND ANTI-TUMOR ANTIBIOTICS, SPECIFIC FOR DEFINITE DNA BASES
00
65251076577 1983 ANTIBIOTIKI 28 (6): 462-471
ZHUKOVA RA; LAVRENTYEVA GI
USE OF ANTIBIOTICS IN THE SELECTION OF MICROORGANISMS PRODUCING BIOLOGICALLY-ACTIVE SUBSTANCES
00
653256907 1984 ANTIBIOTIKI 29 (5): 391-393
SMOLYANSKAYA AZ; SPASIBINA TV
PHARMACOKINETICS OF MITOMYCIN-C IN ONCOLOGICAL PATIENTS SUBJECTED TO PROLONGED ADMINISTRATION OF THE DRUG
00
6541376908 1984 ANTIBIOTIKI 29 (7): 519-527
KRIVOSHEIN YS; SKURATOVICH AA; TYSHKEVICH LV; RUDKO AP
STUDY ON MUTAGENIC AND CARCINOGENIC EFFECTS OF ANTIMICROBIAL SURFACE-ACTIVE SUBSTANCES
00
6554998459 1991 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS 4 (3): 245-272
BUCHSBAUM DJ; LAWRENCE TS
TUMOR-THERAPY WITH RADIOLABELED MONOCLONAL-ANTIBODIES
033
656341487430 1986 ANTICANCER RESEARCH 6 (4): 605-619
DRIEBERGEN RJ; HOLTHUIS JJM; HULSHOFF A; POSTMAKELDER SJ; VERBOOM W; et al.
ELECTROCHEMISTRY OF POTENTIAL BIOREDUCTIVE ALKYLATING QUINONES - ITS USE IN THE DEVELOPMENT OF NEW AZIRIDINYLQUINONES
121
65752087653 1987 ANTICANCER RESEARCH 7 (6): 1085-1104
STUBBLEFIELD E; SANFORD J
A GENERAL SURVEY OF GENETICS AND CANCER
110
6583237654 1987 ANTICANCER RESEARCH 7 (6): 1245-1250
HILL M; HILLOVA J; BRADA Z; MARIAGESAMSON R
MUTAGENICITY OF METHIONINE OR ITS METABOLIC PRODUCTS IN RSV-TRANSFORMED CHINESE-HAMSTER FIBROBLASTS
00
65912297858 1988 ANTICANCER RESEARCH 8 (3): 471-474
CHEITLIN RA; BODELL WJ
APPLICATION OF AN ELISA PROCEDURE FOR THE QUANTITATION OF BROMODEOXYURIDINE INCORPORATED INTO CELLULAR DNA
05
6603208460 1991 ANTICANCER RESEARCH 11 (3): 1301-1304
YUSA K; SATO W; YAMAZAKI A; TSUKAHARA S; TSURUO T
CROSS-RESISTANCE OF HUMAN MULTIDRUG-RESISTANT CELLS TO MITOMYCIN-C
05
#LCRNCRNode / Date / Journal / AuthorLCSGCS
661398817 1993 ANTICANCER RESEARCH 13 (1): 17-20
WILSON WW; MEBANE EW; HOFFMAN RM
CREATION OF ULTRA-RARE RESTRICTION SITES IN INTACT EUKARYOTIC CHROMOSOMES MEDIATED BY BACTERIAL METHYLASES - AN APPROACH TO SEQUENCING AND ANALYZING TUMOR AND NORMAL GENOMES
00
66210328818 1993 ANTICANCER RESEARCH 13 (3): 655-660
OHARA C; BEPPU T; YAMAGUCHI Y; MASUDA Y; FUKUSHIMA S; et al.
EVALUATION OF A NEW LIPOPHILIC PRODRUG 3',5'-DIOCTANOYL-5-BROMODEOXYURIDINE (BRDU-C8) SUSPENDED IN LIPIODOL AS A RADIOSENSITIZER FOR THE TREATMENT OF AH136B TUMOR
00
6633438999 1994 ANTICANCER RESEARCH 14 (5A): 1727-1733
JESUDASAN RA; SLOVAK ML; SEN S; SRIVATSAN ES
REARRANGEMENT OF CHROMOSOME BAND 11Q13 IN HELA-CELLS
013
66461019456 1997 ANTICANCER RESEARCH 17 (1A): 189-196
Bodey B; Bodey B; Groger AM; Siegel SE; Kaiser HE
Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors
014
6656172735 1972 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1 (1): 73-&
MERCADO CM; TOMASZ M
INHIBITORY EFFECTS OF MITOMYCIN-RELATED COMPOUNDS LACKING C1-C2 AZIRIDINE RING
1415
6666332736 1972 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 22 (5): 373-&
ROSENKRANZ HS; ROSENKRA.S
SILVER SULFADIAZINE - INTERACTION WITH ISOLATED DEOXYRIBONUCLEIC ACID
00
6672223116 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3 (6): 649-656
BLOCK ER; JENNINGS AE; BENNETT JE
5-FLUOROCYTOSINE RESISTANCE IN CRYPTOCOCCUS-NEOFORMANS
156
6687413117 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3 (6): 670-676
PINNEY RJ; SMITH JT
CURING OF AN R-FACTOR FROM ESCHERICHIA-COLI BY TRIMETHOPRIM
313
6691163118 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4 (3): 248-253
COLE MA; ELKAN GH
TRANSMISSIBLE RESISTANCE TO PENICILLIN-G, NEOMYCIN, AND CHLORAMPHENICOL IN RHIZOBIUM-JAPONICUM
0142
6701103119 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4 (4): 495-496
MAJESKI JA; COLE BT
IMMUNOSUPPRESSIVE EFFECT OF 6-MERCAPTOPURINE AND MITOMYCIN-C
11
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6712183491 1974 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 6 (6): 848-852
ISAACSON RE; KONISKY J
STUDIES ON REGULATION OF COLICIN IB SYNTHESIS - REPLICATION OF COL IB-P9 PLASMID DURING COLICIN INDUCTION
03
6722143868 1975 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 7 (5): 507-516
DREWS J; GEORGOPOULOS A; LABER G; SCHUTZE E; UNGER J
ANTIMICROBIAL ACTIVITIES OF 81.723 HFU, A NEW PLEUROMUTILIN DERIVATIVE
060
6731174215 1976 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 9 (1): 36-41
CHABBERT YA; SCAVIZZI MR
CHELOCARDIN-INDUCIBLE RESISTANCE IN ESCHERICHIA-COLI BEARING R-PLASMIDS
122
6744204216 1976 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 9 (6): 928-938
BRYAN LE; VANDENELZEN HM
STREPTOMYCIN ACCUMULATION IN SUSCEPTIBLE AND RESISTANT STRAINS OF ESCHERICHIA-COLI AND PSEUDOMONAS-AERUGINOSA
0123
6754294567 1977 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 12 (1): 84-92
GENTHER CS; SCHOENY RS; LOPER JC; SMITH CC
MUTAGENIC STUDIES OF FOLIC-ACID ANTAGONISTS
215
6761344568 1977 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 12 (3): 383-389
SINHA RP
ACRIFLAVINE-RESISTANT MUTANT OF STREPTOCOCCUS-CREMORIS
02
6778384915 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 13 (1): 19-24
LARUSSO NF; TOMASZ M; KAPLAN D; MULLER M
ABSENCE OF STRAND BREAKS IN DEOXYRIBONUCLEIC-ACID TREATED WITH METRONIDAZOLE
018
6789514916 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 13 (5): 770-783
SUTER W; ROSSELET A; KNUSEL F
MODE OF ACTION OF QUINDOXIN AND SUBSTITUTED QUINOXALINE-DI-N-OXIDES ON ESCHERICHIA-COLI
046
6790174917 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 14 (1): 51-59
NKANGA EJ; HAGEDORN C
DETECTION OF ANTIBIOTIC-PRODUCING STREPTOMYCES INHABITING FOREST SOILS
00
6801294918 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 14 (5): 771-779
MIHELC VA; DUNCAN CL; CHAMBLISS GH
CHARACTERIZATION OF A BACTERIOCINOGENIC PLASMID IN CLOSTRIDIUM-PERFRINGENS CW55
017
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6812315238 1979 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 15 (5): 738-746
VEZINA C; BOLDUC C; KUDELSKI A; AUDET P
BIOSYNTHESIS OF KITASAMYCIN (LEUCOMYCIN) BY LEUCINE ANALOG-RESISTANT MUTANTS OF STREPTOMYCES-KITASATOENSIS
09
6822356258 1982 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 22 (5): 791-799
MCMURRY LM; CULLINANE JC; LEVY SB
TRANSPORT OF THE LIPOPHILIC ANALOG MINOCYCLINE DIFFERS FROM THAT OF TETRACYCLINE IN SUSCEPTIBLE AND RESISTANT ESCHERICHIA-COLI STRAINS
030
6831216578 1983 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 24 (2): 194-200
WHITELEY M; TAYLOR DE
IDENTIFICATION OF DNA HOMOLOGIES AMONG H-INCOMPATIBILITY GROUP PLASMIDS BY RESTRICTION ENZYME DIGESTION AND SOUTHERN TRANSFER HYBRIDIZATION
030
6842196579 1983 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 24 (6): 930-935
TAYLOR DE; GARNER RS; ALLAN BJ
CHARACTERIZATION OF TETRACYCLINE RESISTANCE PLASMIDS FROM CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI
162
6852316909 1984 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 25 (6): 676-682
CATLIN BW
PROBENECID - ANTIBACTERIAL ACTION AGAINST NEISSERIA-GONORRHOEAE AND INTERACTION WITH BENZYLPENICILLIN
07
6862247431 1986 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 29 (2): 320-324
SAMUEL J; GILL MJ; IWASHINA T; TOVELL DR; TYRRELL DL; et al.
PHARMACOKINETICS AND METABOLISM OF E-5-(2-[I-131]IODOVINYL)-2'- DEOXYURIDINE IN DOGS
127
6871407655 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (4): 523-526
SCAVIZZI MR; ALONSO JM; PHILIPPON AM; JUPEAUVESSIERES AM; GUIYOULE A
FAILURE OF NEWER BETA-LACTAM ANTIBIOTICS FOR MURINE YERSINIA-ENTEROCOLITICA INFECTION
221
6881307656 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (10): 1589-1595
MARCHOU B; BELLIDO F; CHARNAS R; LUCAIN C; PECHERE JC
CONTRIBUTION OF BETA-LACTAMASE HYDROLYSIS AND OUTER-MEMBRANE PERMEABILITY TO CEFTRIAXONE RESISTANCE IN ENTEROBACTER-CLOACAE
249
6893187657 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (11): 1803-1808
MICHEAHAMZEHPOUR M; AUCKENTHALER R; REGAMEY P; PECHERE JC
RESISTANCE OCCURRING AFTER FLUOROQUINOLONE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PERITONITIS
078
6901167859 1988 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 32 (1): 24-26
LIEBOWITZ LD; SAUNDERS J; CHALKLEY LJ; KOORNHOF HJ
INVITRO SELECTION OF BACTERIA RESISTANT TO LY146032, A NEW CYCLIC LIPOPEPTIDE
08
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6911128065 1989 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 33 (8): 1184-1187
KAATZ GW; SEO SM; BARRIERE SL; ALBRECHT LM; RYBAK MJ
CIPROFLOXACIN AND RIFAMPIN, ALONE AND IN COMBINATION, FOR THERAPY OF EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS
049
6921138257 1990 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 34 (7): 1376-1380
KAATZ GW; SEO SM
WIN-57273, A NEW FLUOROQUINOLONE WITH ENHANCED INVITRO ACTIVITY VERSUS GRAM-POSITIVE PATHOGENS
018
6931218258 1990 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 34 (11): 2273-2276
NESIN M; SVEC P; LUPSKI JR; GODSON GN; KREISWIRTH B; et al.
CLONING AND NUCLEOTIDE-SEQUENCE OF A CHROMOSOMALLY ENCODED TETRACYCLINE RESISTANCE DETERMINANT, TETA(M), FROM A PATHOGENIC, METHICILLIN-RESISTANT STRAIN OF STAPHYLOCOCCUS-AUREUS
039
6942458461 1991 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 35 (9): 1785-1790
LEMAITRE BC; MAZIGH DA; SCAVIZZI MR
FAILURE OF BETA-LACTAM ANTIBIOTICS AND MARKED EFFICACY OF FLUOROQUINOLONES IN TREATMENT OF MURINE YERSINIA-PSEUDOTUBERCULOSIS INFECTION
110
6951168638 1992 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 36 (6): 1192-1197
KAATZ GW; SEO SM; LAMP KC; BAILEY EM; RYBAK MJ
CI-960, A NEW FLUOROQUINOLONE, FOR THERAPY OF EXPERIMENTAL CIPROFLOXACIN-SUSCEPTIBLE AND -RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS
015
6961308639 1992 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 36 (7): 1441-1446
CONDRA JH; EMINI EA; GOTLIB L; GRAHAM DJ; SCHLABACH AJ; et al.
IDENTIFICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE RESIDUES THAT CONTRIBUTE TO THE ACTIVITY OF DIVERSE NONNUCLEOSIDE INHIBITORS
074
6971389155 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39 (9): 2019-2022
CHARVALOS E; TSELENTIS Y; HAMZEHPOUR MM; KOHLER T; PECHERE JC
EVIDENCE FOR AN EFFLUX PUMP IN MULTIDRUG-RESISTANT CAMPYLOBACTER-JEJUNI
049
6981269156 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39 (11): 2392-2396
HAMZEHPOUR MM; PECHERE JC; PLESIAT P; KOHLER T
OPRK AND OPRM DEFINE 2 GENETICALLY DISTINCT MULTIDRUG EFFLUX SYSTEMS IN PSEUDOMONAS-AERUGINOSA
117
6993279317 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 40 (2): 325-330
Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; et al.
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections
07
7001519318 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 40 (2): 342-348
MartinezMartinez L; HernandezAlles S; Alberti S; Tomas JM; Benedi VJ; et al.
In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins
289

Page 7 of 102: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31   41   51   61   71   81   91  |  101 
Generated by: HistCite 2005.08.29